BlackRock Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $111M | Buy |
3,075,439
+178,716
| +6% | +$6.48M | 0.05% | 393 |
|
|
2016
Q3 | $133M | Sell |
2,896,723
-721,705
| -20% | -$33.2M | 0.07% | 337 |
|
|
2016
Q2 | $182M | Buy |
3,618,428
+176,534
| +5% | +$8.87M | 0.09% | 258 |
|
|
2016
Q1 | $184M | Sell |
3,441,894
-734,241
| -18% | -$39.3M | 0.1% | 242 |
|
|
2015
Q4 | $274M | Buy |
4,176,135
+137,154
| +3% | +$9M | 0.15% | 151 |
|
|
2015
Q3 | $228M | Sell |
4,038,981
-366,853
| -8% | -$20.7M | 0.13% | 177 |
|
|
2015
Q2 | $260M | Buy |
4,405,834
+233,831
| +6% | +$13.8M | 0.14% | 171 |
|
|
2015
Q1 | $260M | Buy |
4,172,003
+418,458
| +11% | +$26.1M | 0.14% | 173 |
|
|
2014
Q4 | $216M | Buy |
3,753,545
+977,837
| +35% | +$56.2M | 0.12% | 200 |
|
|
2014
Q3 | $149M | Buy |
2,775,708
+590,214
| +27% | +$31.7M | 0.09% | 264 |
|
|
2014
Q2 | $115M | Buy |
2,185,494
+361,387
| +20% | +$18.9M | 0.07% | 338 |
|
|
2014
Q1 | $96.4M | Buy |
1,824,107
+1,559,507
| +589% | +$82.4M | 0.06% | 365 |
|
|
2013
Q4 | $10.6M | Sell |
264,600
-233,800
| -47% | -$9.37M | 0.01% | 892 |
|
|
2013
Q3 | $18.8M | Buy |
498,400
+272,600
| +121% | +$10.3M | 0.01% | 769 |
|
|
2013
Q2 | $8.85M | Buy |
+225,800
| New | +$8.85M | 0.01% | 885 |
|